DUGiDocsLevetiracetam versus Phenobarbital. Effects in the neurodevelopment in newborns treated for neonatal seizures: a clinical trial
dc.contributor
dc.contributor.author
dc.contributor.other
dc.date.accessioned
2014-03-21T10:10:45Z
dc.date.available
2014-03-21T10:10:45Z
dc.date.issued
2014
dc.identifier.uri
dc.description.abstract
Purpose: To analyze if the use of Phenobarbital compared with Levetiracetam, it’s associated with more neurodevelopmental problems in newborns treated for neonatal seizures. As a secondary objective identify which are the most affected areas of the neurodevelopment: cognition, socio-‐emotional, motor or language skills.Design: A 5 years long clinical trial administering, with double-‐blind and a randomized distribution of the sample, Phenobarbital or Levetiracetam for the management of neonatal seizures
dc.format.mimetype
application/pdf
dc.language.iso
eng
dc.relation.ispartofseries
Medicina (TFG)
dc.rights
Attribution-NonCommercial-NoDerivs 3.0 Spain
dc.rights.uri
dc.subject
dc.title
Levetiracetam versus Phenobarbital. Effects in the neurodevelopment in newborns treated for neonatal seizures: a clinical trial
dc.type
info:eu-repo/semantics/bachelorThesis
dc.rights.accessRights
info:eu-repo/semantics/openAccess